Cite

HARVARD Citation

    Landau, D. et al. (n.d.). 119: SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial. Lung cancer. pp. S54-. [Online]. 
  
Back to record